Clinical Trial Update: Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the immunogenicity and safety of recombinant hepatitis B vaccine with MPL adjuvant versus without MPL in healthy older adults. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (recombinant) with MPL adjuvant (Hepatitis B vaccine, recombinant with MPL)
• Hepatitis B vaccine (recombinant) without MPL adjuvant (Hepatitis B vaccine, recombinant without MPL)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED